Vaxcyte Jumps on Phase 3 Vaccine Win as Biotech Stocks Set Records
Vaxcyte shares shot up 31 percent after strong Phase 3 results for its pneumococcal vaccine. The news sparked a rally, sending several biotech stocks to fresh 52-week highs.
Illumina 1 article
Illumina is a genomics technology company built around sequencing by synthesis and high-throughput short-read sequencing. Its systems span NovaSeq and MiSeq instruments, library preparation, Infinium genotyping arrays, DRAGEN analysis and BaseSpace informatics, supporting research and clinical genomics workflows. The company tag represents the organization and its integrated sequencing ecosystem; individual instruments, assays and sequencing-by-synthesis chemistry remain separate entities when those technologies are the actual subject.